NB
NBY
Stablecoin Development Corp
$1.52
-1.94%
No data for this timeframe.
Vol
SEC Reports2
Press Releases1
Recent Activity
Apr 6, 2026
SEC
Stablecoin Development Corp (formerly NovaBay Pharmaceuticals) announced updated SKY token holdings of 2.15 billion toke
8-K — Impact 4/10
Mar 31, 2026
earnings_calendar
NBY Q4 2025 Earnings After Market Close — 2026-03-31
Mar 23, 2026
Press
NovaBay Pharmaceuticals (NBY) is rebranding as Stablecoin Development Corporation (SDEV) following a $134 million privat
Impact 7/10
Mar 2, 2026
SEC
NovaBay Pharmaceuticals is seeking stockholder approval for the issuance of shares underlying pre-funded warrants sold i
DEFA14A — Impact 7/10
Analyst Ratings
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| Aug 11, 2023 | Ladenburg Thalmann | MAINTAIN | Buy → Buy |
Latest Reports
NEUTRAL
8-K
4/10
Stablecoin Development Corp (formerly NovaBay Pharmaceuticals) announced updated SKY token holdings of 2.15 billion toke
Apr 6, 2026
MIXED
Press
7/10
NovaBay Pharmaceuticals (NBY) is rebranding as Stablecoin Development Corporation (SDEV) following a $134 million privat
Mar 23, 2026
MIXED
DEFA14A
7/10
NovaBay Pharmaceuticals is seeking stockholder approval for the issuance of shares underlying pre-funded warrants sold i
Mar 2, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 5.5/10.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| Aug 11, 2023 | Ladenburg Thalmann | MAINTAIN | Buy | Buy |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 31, 2026
earnings_calendar
NBY Q4 2025 Earnings After Market Close — 2026-03-31
Mar 23, 2026
m_and_a
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
<p align="center"><em>Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Found